PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
“Prevalence of hypogonadism (low testosterone) in men with cancer (chemotherapy) has been reported between 40% and 90%, which is significantly higher than in the general population.” I beat
Continue reading